LASSEN v. MEDICAL DEVICE BUSINESS SERVICES, INC.

CourtDistrict Court, D. New Jersey
DecidedNovember 30, 2022
Docket3:22-cv-02656
StatusUnknown

This text of LASSEN v. MEDICAL DEVICE BUSINESS SERVICES, INC. (LASSEN v. MEDICAL DEVICE BUSINESS SERVICES, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
LASSEN v. MEDICAL DEVICE BUSINESS SERVICES, INC., (D.N.J. 2022).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

CHARLES GOODINSON,

Plaintiff, Civil Action No. 22-1320 (ZNQ) (TJB)

v. CONSOLIDATED OPINION

JOHNSON & JOHNSON, et. al.

Defendants.

QURAISHI, District Judge THIS MATTER comes before this Court on thirty-three Motions for Remand (the “Motions”) filed by separate plaintiffs who have alleged various injuries as a result of being implanted with a Pinnacle Acetabular Cup System. The Court observed these Motions on its docket and requested that counsel1 confer and propose means to consolidate them to facilitate their disposition. In response, the parties supplied a proposed order (ECF No. 11), which the Court entered as an Order of Consolidation for Remand Purposes Only (the “Consolidation Order”, ECF No.12). Consistent with parties’ request in the Consolidation Order, the Court has considered the briefing they filed regarding remand in Kissel v. Johnson & Johnson, et al., Civil Action No. 3:22- cv-2651. (Consolidation Order ¶ 4). There, Plaintiff William Kissel (“Plaintiff”) filed a brief in

1 To date, Plaintiffs in all of the cases before the Court are represented by a single law firm: Wilentz, Goldman & Spitzer, PA. support of his Cross-Motion2 for Remand (“Moving Br.”, ECF No. 4), and Defendants Medical Device Business Services, Inc. and DePuy Synthes Sales, Inc. (collectively, “Removing Defendants”) filed a brief in opposition. (“Opp’n Br.”, ECF No. 6.) Having reviewed the parties’ submissions filed in connection with the Motion and having declined to hold oral argument

pursuant to Federal Rule of Civil Procedure 78(b) and Local Civil Rule 78.1(b), for the reasons set forth below and for good cause shown, Plaintiff’s Motion for Remand will be GRANTED, as will the Motions for Remand filed by the other similarly situated plaintiffs. I. BACKGROUND AND PROCEDURAL HISTORY On April 5, 2022, Plaintiff filed a Complaint (“Compl.”) in the Superior Court of New Jersey, Middlesex County, claiming damages under New Jersey’s Products Liability Act (“NJPLA”), against four Defendants: Johnson & Johnson, Johnson & Johnson Services, Inc., Medical Device Business Services, Inc., and DePuy Synthes Sales. (See Compl. ECF No. 1-1.) Defendants Medical Device Business Services Inc., and DePuy Synthes Sales, Inc. removed this matter on May 5, 2022. (See ECF No. 1.) Removing Defendants attached a

Declaration of Douglas K. Chia with its Notice of Removal. (“Chia Decl.”, ECF No. 1-2.) The Complaint sets forth the following relevant facts. Plaintiff was a resident of Colorado. (Compl. ¶ 1.) Defendant Johnson & Johnson is the parent company of Defendant Johnson & Johnson Services, Inc. (Id. ¶ 2.) Defendants Johnson & Johnson and Johnson & Johnson Services,

2 The Motion for Remand in Kissel, like many but not all of the other thirty-two cases, was filed as a cross-motion to Defendants’ Motion to Stay the cases pending their transfer to MDL 2244 in the Northern District of Texas. MDL 2244 was established in 2011 and, while it has not yet closed as of the most recent JPML Report entered on November 15, 2022, the JPML has nevertheless denied transferring Goodinson and other more recent would-be member cases on the basis that the MDL has reached the point where the benefits of such a transfer are outweighed by the effects of adding new cases. See Order Vacating Conditional Transfer Orders (3:22-cv-1320 ECF No. 7 at 2). Accordingly, Defendants have since withdrawn the Motions to Stay they filed in each of the remaining cases before the Court (ECF No. 15.), leaving pending only the Motions for Remand. Inc. (“collectively, Johnson & Johnson Defendants”) are citizens of the State of New Jersey. (Id. ¶¶ 2, 3.) Removing Defendants are citizens of Indiana and Massachusetts. (Id. ¶¶ 4, 5.) The Complaint alleges that Defendant Johnson & Johnson participated “in developing the product, greenlighted its sale worldwide, held the product out as its own, independently promoted

the product, exercised ultimate controlling authority over the product’s design and promotion, sold the product and derived revenue from its sale such that it is the responsible authority over the research, development, testing, manufacture, production, marketing, promotion, distribution and/or sale of the product at issue in this litigation, known as the DePuy Pinnacle MoM hip replacement system.” (Id. ¶ 7.) The alleged defective product, the DePuy Pinnacle MOM hip replacement system, will hereinafter be referred to as “the Product.” The Notice of Removal alleges that while Defendants Johnson & Johnson and Johnson & Johnson Services, Inc. (collectively, “J&J Defendants”) are in-state defendants, removal was nevertheless proper because J&J Defendants’ were fraudulently joined and their citizenship should therefore be ignored. (NOR ¶ 13.)

II. LEGAL STANDARD The “forum defendant rule” provides that a “civil action otherwise removable solely on the basis of [diversity jurisdiction] may not be removed if any of the parties in interest properly joined and served as defendants is a citizen of the State in which the action is brought.” 28 U.S.C. § 1441(b)(2). Under the doctrine of fraudulent joinder, however, a defendant may still remove a non-diverse case if it can establish that all in-state defendants were sued solely to prevent removal to federal court. Wilson v. Republic Iron & Steel Co., 257 U.S. 92, 97 (1921); Chesapeake & Ohio Railway v. Cockrell, 232 U.S. 146, 147 (1914) (If fraudulent joinder is found, the citizenship of that defendant may be ignored and the action may be removed). Notably, in this context the term “fraudulent joinder” does not require a showing of fraud in the conventional sense; “it in no way reflects on the integrity of plaintiff or of plaintiff's counsel.” Newman v. Forward Lands, Inc., 418 F. Supp. 134, 136 n.1 (E.D. Pa. 1976). The Third Circuit has specifically instructed “that joinder is fraudulent where ‘there is no reasonable basis in

fact or colorable ground supporting the claim against the joined defendant, or no real intention in good faith to prosecute the action against the defendant or seek a joint judgment.’” Boyer v. Snap- on Tools Corp., 913 F.2d 108, 111 (3d Cir. 1990) (quoting Abels v. State Farm Fire & Cas. Co., 770 F.2d 26, 32 (3d Cir. 1985)); Batoff v. State Farm Ins. Co., 977 F.2d 848, 852 (3d Cir. 1992) (describing a claim as not colorable if it is “wholly insubstantial and frivolous”). Accordingly, a court’s determination of fraudulent joinder does not focus on whether a plaintiff's claims are “plausible” under Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) or Rule 12(b)(6), rather it focuses on whether they are more than “frivolous.” In re Briscoe, 448 F.3d at 218; Batoff, 977 F.2d at 852. Importantly, “it is possible that a party is not fraudulently joined, but that the claim against that party ultimately is dismissed for failure to state a claim upon which relief may be granted.” In re

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
LASSEN v. MEDICAL DEVICE BUSINESS SERVICES, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/lassen-v-medical-device-business-services-inc-njd-2022.